94 related articles for article (PubMed ID: 4390991)
1. A comparative study of the effects of quinidine and a newer antiarrhythmic agent, disopyramide, on mammalian myocardial metabolism of glucose and oxidative phosphorylation.
Mathur PP; Mokler CM
Arch Int Pharmacodyn Ther; 1969 Apr; 178(2):285-95. PubMed ID: 4390991
[No Abstract] [Full Text] [Related]
2. Metabolic effects of bunaftine, a new antiarrhythmic agent: comparison with quinidine, ajmaline, procainamide, xylocaine and propranolol.
Castellucci A
Arzneimittelforschung; 1976 Feb; 26(2):241-4. PubMed ID: 947206
[TBL] [Abstract][Full Text] [Related]
3. Species differences in the response of mammalian myocardial fatty acid metabolism to quinidine and disopyramide.
Mathur PP; Mokler CM
Proc Soc Exp Biol Med; 1970 Jul; 134(3):613-6. PubMed ID: 5431347
[No Abstract] [Full Text] [Related]
4. Comparative antiarrhythmic activity of quinidine combined with propranolol and with sotalol.
Lawson JW; Wojciechowski NJ
Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):72-86. PubMed ID: 6111984
[TBL] [Abstract][Full Text] [Related]
5. Effects of 4 antiarrhythmic drugs on sinoatrial conduction time in isolated and blood-perfused dog atria.
Shimotori M; Kobayashi M; Chiba S
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):67-79. PubMed ID: 6721625
[TBL] [Abstract][Full Text] [Related]
6. Effects of some antiarrhythmic agents on dog heart mitochondrial oxidative phosphorylation.
Alto LE; Dhalla NS
Eur J Pharmacol; 1979 Nov; 59(3-4):311-4. PubMed ID: 527652
[TBL] [Abstract][Full Text] [Related]
7. Effect of antiarrhythmic agents on cardiac metabolism.
Belliveau RE; Covino BG
Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):130-8. PubMed ID: 5650322
[No Abstract] [Full Text] [Related]
8. Mechanisms of the atrium-specific positive inotropic activities of quinidine- and atropine-like agents in rats.
Deng XF; Mulay S; Chemtob S; Varma DR
J Pharmacol Exp Ther; 1997 Apr; 281(1):322-9. PubMed ID: 9103513
[TBL] [Abstract][Full Text] [Related]
9. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
Terhaag B; Förster W
Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213
[No Abstract] [Full Text] [Related]
10. Effects of disopyramide on the A-V conduction system.
Dean RR; Ferguson DM
Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):183-9. PubMed ID: 5102511
[No Abstract] [Full Text] [Related]
11. Alteration of excitability of the rabbit ventricle by quinidine, disopyramide and pronethalol.
Deshpande SS; Mokler CM
Arch Int Pharmacodyn Ther; 1967 Sep; 169(1):55-65. PubMed ID: 4383277
[No Abstract] [Full Text] [Related]
12. The effect of quinidine, propranolol and their combination on experimental atrial and ventricular arrhythmias.
Lawson JH; Wojciechowski NJ
Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):235-43. PubMed ID: 596978
[TBL] [Abstract][Full Text] [Related]
13. Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine.
Parmley WW; Braunwald E
J Pharmacol Exp Ther; 1967 Oct; 158(1):11-21. PubMed ID: 6054071
[No Abstract] [Full Text] [Related]
14. The effect of propranolol on myocardial oxidative processes.
Bada V; Gvozdják A; Krutý F; Niederland TR; Gvozdják J
Cor Vasa; 1979; 21(3):215-20. PubMed ID: 535407
[TBL] [Abstract][Full Text] [Related]
15. A microelectrophysiological analysis of the pharmacodynamic basis for quinidine-propranolol antiarrhythmic potentiation.
Iansmith DH; Bandura JP; Nash CB
J Pharmacol Exp Ther; 1981 Dec; 219(3):651-8. PubMed ID: 7299688
[No Abstract] [Full Text] [Related]
16. Propranolol and experimental myocardial infarction: substrate effects.
Opie LH; Thomas M
Postgrad Med J; 1976; 52 Suppl 4():124-32. PubMed ID: 787952
[TBL] [Abstract][Full Text] [Related]
17. Quantitative comparison of the anticholinergic and antiarrhytmic actions of disopyramide and quinidine.
Pérez A; Ledea N; Hermández K; Garcia-Barreto D
Pol J Pharmacol Pharm; 1977; 29(5):527-32. PubMed ID: 593967
[TBL] [Abstract][Full Text] [Related]
18. A cardiac antiarrhythmic screening test in the rat: the effects of lidocaine, propranolol and quinidine.
Baker T; Erker EF
Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):97-102. PubMed ID: 7387264
[TBL] [Abstract][Full Text] [Related]
19. The effects of oligomycin and 2,4-dinitrophenol on the mechanical performance and metabolism of the perfused rat heart.
Lochner A; Brink AJ
Clin Sci; 1969 Aug; 37(1):191-204. PubMed ID: 5822527
[No Abstract] [Full Text] [Related]
20. [The effect of some antiarrhythmic drugs on systolic time intervals in normal subjects (author's transl)].
Breithardt G; Jochum E; Kuhn H; Seipel L
Z Kardiol; 1978 Oct; 67(10):6,0-7. PubMed ID: 366939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
